Last61.27 +2.23 (+3.78%)
23.56 - 66.61
52 Week Range
Technical Indicators (Daily)
NEW YORK, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, w...
In this article we will take a look at whether hedge funds think Progyny, Inc. (NASDAQ:PGNY) is a good investment right now. We check hedge fund and billionaire investor sentiment before delving into ...
David Schlanger, Chief Executive Officer at Progyny (NASDAQ:PGNY), made a large buy and sell of company shares on October 5, according to a new SEC filing. What Happened: A Form 4 filing from the U.S....
When you're investing in growth stocks, especially in the healthcare space, you might be willing to accept a company's unprofitability for a period of time, provided its revenue is increasing. All th...
Norman Payson, Director at Progyny (NASDAQ:PGNY), made a large insider sell on September 30, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commiss...
Disclaimer: The data contained in Super Surge website is not necessarily real-time nor accurate and may differ from the actual market data. Prices, volumes, ratios, charts and indicators are indicative and not appropriate for trading purposes. Super Surge doesn't bear any responsibility for any trading losses you might incur as a result of using this data.